Jager PL - Search Results

1

L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.

Jager PL, Meijer WG, Kema IP, Willemse PH, Piers DA, de Vries EG. Jager PL, et al. J Nucl Med. 2000 Nov;41(11):1793-800. J Nucl Med. 2000. PMID: 11079485 Free article.

2

Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.

Meijer WG, van der Veer E, Jager PL, van der Jagt EJ, Piers BA, Kema IP, de Vries EG, Willemse PH. Meijer WG, et al. Among authors: jager pl. J Nucl Med. 2003 Feb;44(2):184-91. J Nucl Med. 2003. PMID: 12571207 Free article.

3

Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.

Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA. Jager PL, et al. J Nucl Med. 1998 Apr;39(4):699-706. J Nucl Med. 1998. PMID: 9544684 Free article.

4

Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors.

Jager PL, Franssen EJ, Kool W, Szabó BG, Hoekstra HJ, Groen HJ, de Vries EG, van Imhoff GW, Vaalburg W, Piers DA. Jager PL, et al. J Nucl Med. 1998 Oct;39(10):1736-43. J Nucl Med. 1998. PMID: 9776279 Free article.

5

Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.

Jager PL, Plaat BE, de Vries EG, Molenaar WM, Vaalburg W, Piers DA, Hoekstra HJ. Jager PL, et al. Clin Cancer Res. 2000 Jun;6(6):2252-9. Clin Cancer Res. 2000. PMID: 10873075

6

Uptake mechanisms of L-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1.

Jager PL, de Vries EG, Piers DA, Timmer-Bosscha H. Jager PL, et al. Nucl Med Commun. 2001 Jan;22(1):87-96. doi: 10.1097/00006231-200101000-00013. Nucl Med Commun. 2001. PMID: 11233558

7

Radiolabeled amino acids: basic aspects and clinical applications in oncology.

Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Jager PL, et al. J Nucl Med. 2001 Mar;42(3):432-45. J Nucl Med. 2001. PMID: 11337520 Free article. Review.

8

L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.

Jager PL, Groen HJ, van der Leest A, van Putten JW, Pieterman RM, de Vries EG, Piers DA. Jager PL, et al. J Nucl Med. 2001 Apr;42(4):579-85. J Nucl Med. 2001. PMID: 11337545 Free article.

9

Routine bone scintigraphy in primary staging of soft tissue sarcoma; Is it worthwhile?

Jager PL, Hoekstra HJ, Leeuw J, van Der Graaf WT, de Vries EG, Piers D. Jager PL, et al. Cancer. 2000 Oct 15;89(8):1726-31. doi: 10.1002/1097-0142(20001015)89:8<1726::aid-cncr12>3.0.co;2-v. Cancer. 2000. PMID: 11042567

10

Treatment with radioactive (89)strontium for patients with bone metastases from prostate cancer.

Jager PL, Kooistra A, Piers DA. Jager PL, et al. BJU Int. 2000 Nov;86(8):929-34. doi: 10.1046/j.1464-410x.2000.00780.x. BJU Int. 2000. PMID: 11069429 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters